Results 161 to 170 of about 17,340 (213)

Towards elimination of genital schistosomiasis in Africa: Outlining strategic public health objectives and measures to protect future generations. [PDF]

open access: yesParasitology
Oluwole AS   +12 more
europepmc   +1 more source

Exploring the consequences of female genital schistosomiasis among women in endemic districts in Southern Ghana: a phenomenological study using photovoice methodology. [PDF]

open access: yesBMC Womens Health
Dalaba MA   +8 more
europepmc   +1 more source

Praziquantel analogs with activity against juvenile Schistosoma mansoni

open access: yesBioorganic and Medicinal Chemistry Letters, 2010
Six amide and four urea derivatives of praziquantel were synthesized and tested for antischistosomal activity against juvenile and adults stages of Schistosoma mansoni in infected mice. Only one of these had significant activity against adult worms, but,
Yuxiang Dong   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Praziquantel resistance

Expert Opinion on Drug Discovery, 2007
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Sanaa S Botros
exaly   +3 more sources

Praziquantel

Parasitology Research, 2003
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
openaire   +2 more sources

Home - About - Disclaimer - Privacy